HOME
RESOURCE LIBRARY
LEARNING COMMUNITY
FOR PATIENTS
NEWS & EVENTS
News
Event Calendar
Event Recordings
ABOUT
Overview
Quality Initiatives
Practice Map
Team
Contact Us
LEARN
Video
Publications
Care For All
LCD Patient Simulator
SPECIALTY CARE
Nephrology
Endocrinology
COVERAGE CHECKER
ADMIN PORTAL
PATIENT DATA DASHBOARD

NEWS & EVENTS

NewsEvent CalendarEvent Recordings

ABOUT

OverviewQuality InitiativesPractice MapTeamContact Us

LEARN

VideoPublicationsCare For AllLCD Patient Simulator

SPECIALTY CARE

NephrologyEndocrinology
COVERAGE CHECKER
ADMIN PORTAL
PATIENT DATA DASHBOARD
MCT2D Logo
RESOURCE LIBRARYLEARNING COMMUNITYFOR PATIENTS
Search Icon

MCT2D Clinician Decision Aid: SGLT2i / GLP-1 RA for Type 2 Diabetes

DOWNLOAD RESOURCE

Updated: 10/20/25

Newly updated for 2025!
SGLT2 inhibitors and GLP-1 receptor agonists are first-line treatments for T2D in patients with cardiorenal disease. This aid is meant to be used alongside your own clinical judgment, guideline-directed therapy, and prescribing information to guide individualization of diabetes treatment.
Lead clinical author is Heidi Diez, PharmD, clinical pharmacist, with Michael Heung, MD, nephrologist.
MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org

ResourcesPoint of CareMy BookmarksMembersEventsNewsPatientsSpecialty CareNephrology
AboutOverviewQuality InitiativesJoinHealth EquityTeam
A nonprofit and independent licensee of the Blue Cross Blue Shield Association

Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.